Skip to main content
Livermore
Livermore
ZHEN

Emerald Advisers, LLC

SEC CIK
0001015083
Latest filing
Aug 5, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of RARE by Emerald Advisers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−212,358−100.0%Sold outHolders
Q4 2025212,358$4.88M0.2%−206,208−49.3%ReducedHolders
Q3 2025418,566$12.6M0.4%−42,836−9.3%ReducedHolders
Q2 2025461,402$16.8M0.6%−54,826−10.6%ReducedHolders
Q1 2025516,228$18.7M0.8%−2,100−0.4%ReducedHolders
Q4 2024518,328$21.8M0.8%−51,470−9.0%ReducedHolders
Q3 2024569,798$31.7M1.2%+83,116+17.1%AddedHolders
Q2 2024486,682$20.0M0.8%−1,456−0.3%ReducedHolders
Q1 2024488,138$22.8M0.9%+6,000+1.2%AddedHolders
Q4 2023482,138$23.1M1.0%−9,551−1.9%ReducedHolders
Q3 2023491,689$17.5M0.8%−60,447−10.9%ReducedHolders
Q2 2023552,136$25.5M1.1%+61,975+12.6%AddedHolders
Q1 2023490,161$19.7M0.9%+145,436+42.2%AddedHolders
Q4 2022344,725$16.0M0.8%−2,356−0.7%ReducedHolders
Q3 2022347,081$14.4M0.7%+145,864+72.5%AddedHolders
Q2 2022201,217$12.0M0.6%−22,735−10.2%ReducedHolders
Q1 2022223,952$16.3M0.6%−11,793−5.0%ReducedHolders
Q4 2021235,745$19.8M0.7%+39,621+20.2%AddedHolders
Q3 2021196,124$17.7M0.6%−14,119−6.7%ReducedHolders
Q2 2021210,243$20.0M0.7%−18,125−7.9%ReducedHolders
Q1 2021228,368$26.0M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.